Literature DB >> 3804896

Resistance to antibiotics at medical centres in different parts of the world.

T F O'Brien.   

Abstract

The diameters of the zones of inhibition of consecutive clinical isolates around antibiotic susceptibility test discs at medical centres in different parts of the world were computer filed and analysed by a series of programs that evaluate test quality and compare results. Percentages of isolates resistant to ampicillin at 18 centres ranged from 16 to 73 for Escherichia coli and from 3 to 56 for Proteus mirabilis. Percentages resistant to chloramphenicol ranged from 2 to 48 for E. coli, from 5 to 52 for Klebsiella pneumoniae, and from 8 to 67 for Serratia marcescens. Gentamicin resistance did not exceed 4% at any of 18 centres and was less than 1 at 14 of them for isolates of E. coli, while K. pneumoniae showed less than 2% resistance at six centres but averaged 22% at another eight. Multi-resistant isolates were ten-fold more frequent at eight centres than at the remaining six. Too few centres were sampled to characterize individual countries except in the United States where resistance seemed generally less prevalent.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3804896     DOI: 10.1093/jac/18.supplement_c.243

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

Review 1.  The emergence of antibiotic resistance: myths and facts in clinical practice.

Authors:  J M Hamilton-Miller
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

2.  In vitro activity of the tricyclic beta-lactam GV104326.

Authors:  R Wise; J M Andrews; N Brenwald
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

3.  Occurrence of multiple antibiotic resistance and R plasmids in Enterobacteriaceae isolated from children in the Sudan.

Authors:  P Shears; G Suliman; C A Hart
Journal:  Epidemiol Infect       Date:  1988-02       Impact factor: 2.451

4.  A regional survey of the resistance to beta-lactam antibiotics in clinical isolates of (facultative) aerobic micro-organisms.

Authors:  E E Stobberingh; J M Philips; A W Houben; C P van Boven
Journal:  Drugs       Date:  1988       Impact factor: 9.546

5.  Three-year survey of amikacin use and aminoglycoside resistance in a general hospital in Belgium.

Authors:  R Vanhoof; J M Hubrechts; H J Nyssen; E Roebben
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

Review 6.  Risk factors for the spread of antibiotic-resistant bacteria.

Authors:  G G Rao
Journal:  Drugs       Date:  1998-03       Impact factor: 9.546

7.  RWJ-54428 (MC-02,479), a new cephalosporin with high affinity for penicillin-binding proteins, including PBP 2a, and stability to staphylococcal beta-lactamases.

Authors:  Francois Malouin; Johanne Blais; Suzanne Chamberland; Monica Hoang; Craig Park; Christin Chan; Kristina Mathias; Samia Hakem; Kelly Dupree; Eric Liu; Tien Nguyen; Michael N Dudley
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.